David Hong, MD on Is there Benefits of Larotrectinib in Patients with Cancer and NTRK Gene Fusions? @MDAndersonNews #AACR2020

David Hong, MD on Is there Benefits of Larotrectinib in Patients with Cancer and NTRK Gene Fusions? @MDAndersonNews #AACR2020

Cancer-News

2 weeks
3 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David Hong, MD of MD Anderson Cancer Center @MDAndersonNews discusses at this year's virtual AACR the efficacy and safety of larotrectinib in patients with cancer and NTRK gene fusions or other alterations.
Up Next Autoplay